Serentis Inc., a
PRESS RELEASE
Serentis, a privately owned biopharmaceutical company, announced today that it has closed a Gbp10 million ($20 million) financing, expanding the total of its Series A financing to Gbp15.3 million ($30 million). The funding will be used to advance and expand Serentis' dermatology pipeline.
In July 2007, Serentis announced a